ProBioGen was Granted a New Patent for DirectedLuck® Transposase Technology

Berlin, Germany - December 14th, 2023

ProBioGen announced today that the Japan Patent Office (JPO) issued the first patent for the company’s DirectedLuck® technology. The powerful gene delivery system is based on a highly active transposase fusion variant that enables epigenetic targeting and a carefully designed transposon.